Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 3 Colorectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Heart Defects, Congenital 1 Gastrointestinal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Paclitaxel 177 Carboplatin 177 Bevacizumab 72 Topotecan 55 liposomal doxorubicin 54 Gemcitabine 53 Cisplatin 46 Docetaxel 39 Cyclophosphamide 37 olaparib 32 Filgrastim 31 pembrolizumab 29 Doxorubicin 26 niraparib 24 Taxes 23 Drug Therapy 23 Peripheral Blood Stem Cell Transplantation 20 Etoposide 17 veliparib 15 Nivolumab 14 sargramostim 13 Surveys and Questionnaires 13 Immunoglobulin G 13 Disulfides 13 pazopanib 12 Ifosfamide 12 Albumin-Bound Paclitaxel 12 durvalumab 11 atezolizumab 11 Trabectedin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ovarian Neoplasms × Enhanced Recovery After Surgery × Clear all

NCT02172638 2019-09-30

PROFAST

Hospital Universitari Vall d'Hebron Research Institute

Phase NA Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡